David Geffen School of Medicine, UCLA

Los Angeles, California 90095-1769

0 studies enrolling now · 19 studies all time

What they study most

Bacteremia, COVID-19 Pneumonia, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Duchenne Muscular Dystrophy, EBV Related PTCL, NOS, EBV-Positive DLBCL, NOS, EBV-Related Hodgkin Lymphoma, EBV-Related Lymphoproliferative Disorder, EBV-Related Non-Hodgkin Lymphoma, EBV-Related PTLD, Epstein-Barr Virus Associated Lymphoma, Friedreich's Ataxia

Studies at this site

• Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
• An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas — Stopped early
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial — Completed
• Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia — Completed
• Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients — Completed
• A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia — Completed
• Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men — Completed
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension — Completed
• CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC) — Completed
• Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody — Completed
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil — Withdrawn before enrolling
• Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan — Withdrawn before enrolling
• Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection — Completed
• REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT — Withdrawn before enrolling
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis — Stopped early
• Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy — Completed
• Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics — Stopped early